The Golden Helix Symposia

The Concept
The Golden Helix Symposia series are named after the house of Francis Crick (“The Golden Helix”; 19/20 Portugal Place, Cambridge, UK) to emphasize their focus on human genomics and personalized medicine. The topic of these symposia revolves around the fields of genomic and personalized medicine. In particular, these symposia series have the following features:

  • Symposia topics are selected by Golden Helix Institute’s International Advisory Council of distinguished research scientists from academia, government, and industry.
  • New and often ground- breaking science is presented at every meeting.
  • Symposia range in length from 2 to 3 days
  • Average attendance is 450 participants, coming from various countries worldwide.
  • Scientific excellence is ensured where important collaborations are formed, careers are enhanced, and new scientific breakthroughs are presented
  • Participants are staff scientists, post-doctoral fellows and students from academia, working in the field of personalized research, and scientists from pharmaceutical and biotechnology industries, government agencies and private and research foundations,
  • Conference venues are usually prestigious locations in major cities or summer retreats in Southern Mediterranean or Eastern regions

UPCOMING SYMPOSIUM: 3rd Global Genomic Medicine Collaborative Conference

Welcome

3rd Global Genomic Medicine Collaborative Conference

Implementing Genomic Medicine into Practice

April 27-29, 2017, Athens, Greece

 

The 3rd Global Genomic Medicine Collaborative Conference will be organized in Athens, Greece, April 27-29, 2017.

The meeting will be organized by the Global Genomic Medicine Collaborative and the Golden Helix Foundation, as the local host. The 3rd Global Genomic Medicine Collaborative Conference is the first to be organized in Europe, following the successful events in the United States in 2014 and Singapore in 2015 and will focus on the implementation of Genomic Medicine into clinical practice.

Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.

 

The 3rd Global Genomic Medicine Collaborative Conference organizing Committee

 

Organized by:

Local Organizer:

 

              
         

Endorsed by:

 

  

 

About G2MC

The Global Genomic Medicine Collaborative

 

Overview

The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in Genomic Medicine Summit, the purpose of G2MC is to identify opportunities and foster global collaborations for enabling the demonstration of value and the effective use of genomics in medicine. Engaging multiple stakeholders across the globe, the G2MC group, under the auspices of the Roundtable on Genomics and Precision Health, seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally. To accomplish these goals, seven working groups were created, including communications, education, evidence, IT/bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.

Specifically, it is intended to:

  • Serve as nexus, clearinghouse, and knowledge base for genomic medicine activities globally;
  • Develop opportunities for global genomic medicine demonstration projects (implementation and outcomes research) and;
  • Capture and disseminate best practices for genomic medicine (in bioinformatics, education, evidence, pharmacogenomics, policy) across the global genomic medicine community.

 

Current Activities

The purpose and goals of the Global Genomic Medicine Collaborative (G2MC):

  • Develop projects with global participation
    • Opportunities to disseminate learnings for genomic medicine implementation
    • Educational platforms to support genomic medicine projects
    • Community engagement and access to global genomic medicine expertise
  • Creation of a registry or catalog of genomic medicine projects and programs across the globe to stimulate collaboration and efficiency in translation
  • Be a global policy forum for genomic medicine
    • Mapping the global genomic medicine landscape particularly as it relates to policy and implementation
  • Global eradication of preventable Stevens Johnson Syndrome/Toxic Epidermal Necrolysis

 

Previous Conferences 

2nd G2MC Conference; November 6-7, 2015, Singapore - Implementing Genomic Medicine into Practice

The meeting objectives were to:

  • Highlight nations or organizations around the world that are implementing genomic medicine into practice
  • Foster/facilitate collaborations to enable the implementation of genomic medicine
  • Highlight best practices and lessons learned to enable others to effectively implement genomic medicine approaches
  • Identify and develop solutions for overcoming obstacles to genomic medicine implementation
  • Identify and discuss regulations and policies that impact the implementation of genomic medicine
  • Create a global tool box for implementation of genomic medicine into practice

Agenda

Attendee List

G2MC Group Photo

 

1st G2MC Conference; January 8-9, 2014, Washington DC, USA - Global Leaders in Genomic Medicine

The goals of the meeting were to:

  • Identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts.
  • Identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field.
  • Identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes.
  • Discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.

 

Venue

Venue of the 3rd Global Genomic Medicine Collaborative Conference


The 3rd Global Genomic Medicine Collaborative Conference will be held in the DIVANI Apollon Palace and Thalasso*****.

Divani Apollon Palace and Thalasso is a member of the Leading hotels of the world. This is a luxury beach resort in Athens situated in the exclusive area of Vouliagmeni, just 18km from the city centre. Guests enjoy, the pleasure of a private beach and an award winning Spa, the only one offering Thalassotherapy in the whole Attica region and one of the best Thalassotherapy centers in the Mediterranean.

Divani Apollon Palace and Spa is an excellent hotel for both leisure and business and offers quiet luxury at the prestigious Athenian Riviera.

Here is a short video about Athens

 

Speakers

Conference Organizing Committee

Geoff Ginsburg (Durham, NC, USA)

Robyn Ward (Melbourne, Australia; Co-chair)

George P. Patrinos (Patras, Greece; Local Chair)

 

Fahd Al-Mulla (Safat, Kuwait)

Vajira Dissanayake (Colombo, Sri Lanka)

Peter Goodhand (Montreal, Canada)

Theodora Katsila (Patras, Greece)

Bruce Korf (Birmingham, AL, USA)

Teri Manolio (Baltimore, MD, USA)

Alan Shuldiner (Tarrytown, NY, USA)

 

Keynote Speakers

Victor Dzau (Washington DC, USA)

Stylianos Antonarakis (Geneva, Switzerland)

 

Speakers and Moderators

Takeya Adachi (Tokyo, Japan)

Spiros Agathos (Urcuqui, Ecuador)

Fahd Al-Mulla (Safat, Kuwait)

François Bernier (Toronto, Canada)

Jeffrey Braithwaite (Melbourne, Australia)

Mark Caulfield (London, UK)

Wasun Chantratita (Bangkok, Thailand)

Collet Dandara (Cape Town, South Africa)

Vajira Dissanayake (Colombo, Sri Lanka)

Geoff Ginsburg (Durham, NC, USA)

Peter Goodhand (Montreal, Canada)

Sue Hill (London, UK)

Magnus Ingelman-Sundberg (Stockholm, Sweden)

Federico Innocenti (Chapel Hill, NC, USA)

Said Ismail (Doha, Qatar)

Summer Kahlon (Satellite beach, FL, USA)

Bruce Korf (Birmingham, AL, USA)

Dhavendra Kumar (Cardiff, Wales)

Guilherme Suarez-Kurtz (Rio de Janeiro, Brazil)

Alberto Lecaros (Santiago, Chile)

Yixue Li (Shanghai, P.R. China)

Catalina Lopez-Correa (Vancouver, Canada)

Laura Lyman Rodriguez (Baltimore, MD, USA)

Teri Manolio (Baltimore, MA, USA)

George P. Patrinos (Patras, Greece)

Markus Paulmichl (Vienna, Austria)

Sir Munir Pirmohamed (Liverpool, UK)

Martin Reese (Oakland, CA, USA)

Gad Rennert (Haifa, Israel)

Gabriella Repetto (Santiago, Chile)

Ron H. van Schaik (Rotterdam, the Netherlands)

Alan Shuldiner (Tarrytown, NY, USA)

Andrew Sinclair (Melbourne, Australia)

Jesse Swen (Leiden, the Netherlands)

Patrick Tan (Durham, NC, USA)

Domenica Taruscio (Rome, Italy)

Aspasia Tsezou (Larissa, Greece)

Joris Veltman (Newcastle, UK)

Robyn Ward (Melbourne, Australia)

Grant Wood (Montreal, Canada)

Sarah Wordsworth (Oxford, UK)

Marc S. Williams (Philadelphia, PA, USA)


 

Scientific Program

Scientific Program

 

Day 1 – Thursday April 27, 2017

 

10:00 - 13:00 Registration

 

13:00 - 13:10       Welcoming Remarks

Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia

George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras, Greece

 

13:10 - 13:25       Welcome from Greek Genetics Society

Aspasia Tsezou, President, Hellenic Association of Medical Geneticists, Greece

 

13:25 - 13:55       Keynote Lecture #1

Victor Dzau, President, National Academy of Medicine, USA

 

SESSION I: LARGE_SCALE NATIONAL SEQUENCING PROGRAMS: IMPACT ON CLINICAL MEDICINE

Moderator: Alan Shuldiner, Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA

 

14:00     The Qatar Genome Program; An Overview

Said Ismail, Programme Manager, Genome Qatar, Qatar

14:15     United States: PMI and Million Veterans Program

Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, USA

14:30     China’s Precision Medicine Initiative

Yixue Li, Professor, Shanghai Institutes for Biological Sciences, China

14:45     UK: 100,000 Genomes Project

Mark Caulfield, Co-Director, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, UK

15:00     Australian Genomics Health Alliance: implementing genomics into health care

Andrew Sinclair, Deputy Director, Murdoch Children’s Research Institute, Australia

15:15     The Clalit Israeli 100K Personalized Medicine RCT

Gad Rennert, Director, Clalit National Israeli Cancer Control Center, Israel

 

15:30 Panel discussion

Opening remarks: Chen-Yang Shen, Chief Executive, Taiwan Biobank, Taiwan

 

16:00 - 16:15 COFFEE BREAK

 

SESSION II: PROGRESS IN DIAGNOSING RARE DISEASES _ INTERNATIONAL OPPORTUNITIES

Moderator: Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute (USA)

 

16:15     Undiagnosed severe intellectual disability

Joris Veltman, Director, Institute of Genetic Medicine, Newcastle University, UK

16:30     Undiagnosed Diseases Network International

Domenica Taruscio, Director, Istituto Superiore di Sanita (ISS), Italy

16:45     Next generation sequencing for rare pharmacogenomics variants

Magnus Ingelman-Sundberg, Professor, Karolinska Institutet, Sweden

17:00     Japan’s Initiative on Rare and Undiagnosed Diseases (IRUD): Towards integrative diagnosis network for universal healthcare system

Takeya Adachi, AMED Program Officer, Japan Agency for Medical Research & Development (AMED), Japan

17:15     Enhanced Care for Rare Diseases Canada

François Bernier, Associate Professor, Department of Medical Genetics, Alberta Children’s Hospital, Canada

17:30     The University of Alabama at Birmingham Undiagnosed Diseases Program

Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham, USA

17:45 - 18:15 Panel discussion

 

18:30 WELCOME COCKTAIL RECEPTION

 

Day 2 – Friday April 28, 2017

08:15     Opening Remarks

Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia

08:20 Keynote Introduction

George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology,University of Patras, Greece

 

08:25 Keynote Lecture #2

Stylianos Antonarakis, Professor and Chairman of Genetic Medicine, University of Geneva Medical School, Switzerland

 

SESSION III: NATIONAL GENOMIC MEDICINE PROGRAMS: IMPLEMENTATION

Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University

 

09:00     Kuwait Genome Program

Fahd Al-Mulla, Director of Genomic Medicine Center and Professor of Molecular Pathology, Kuwait University, Dasman Diabetes Institute, Kuwait

09:15     Implementing Genomic Medicine in Sri Lanka [pre-taped video presentation]

Vajira Dissanayake, Chair & Professor of Anatomy and Medical Geneticist, University of Colombo, Sri Lanka

09:30     South America

Gabriella Repetto, Director, Center for Genetics and Genomics, Universidad del Desarrollo, Chile

09:45     The economics of next-generation sequencing

Sarah Wordsworth, Associate Professor, Oxford University, UK

10:00     National Scale Precision Medicine in Singapore

Patrick Tan, Professor, Cancer and Stem Cell Biology Program, Duke NUS Medical School, Singapore

10:15     IGNITE network

Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

10:30 Panel discussion

 

SESSION IV: DATA SCIENCE (WITH GA4GH)

Moderators: Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Grant Wood, Senior IT Strategist, Clinical Genetics Institute at Intermountain Healthcare

 

11:00     Accurate and Rapid WGS Interpretation with Fabric Genomics

Martin Reese, Co-founder, President, and Chief Scienti_c O_cer, Fabric Genomics, USA

11:15     Clinical contextualization of lab results

Marc S. Williams, Director, Genomic Medicine Institute, Geisinger Health System, USA

11:30     Oracle Family Health History Project

Summer Kahlon, Director, Care Innovation, Oracle Health Sciences, USA

Grant Wood, Senior Strategist, Intermountain Healthcare Clinical Genetics Institute, USA

11:45     Establishing a Longitudinal Genetic/Genomic-Based EHR for Clinical Care

Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Canada

12:00 Q&A with session speakers and audience

Discussion topic: What are the issues in your country to accomplish the goals of a longitudinal genomic patient record?

 

12:30 LUNCH BREAK

 

SESSION V: POLICY AND WORKFORCE GENERATION

Moderator: Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia, Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham

 

13:30     The Implementation of Genomic Medicine in the NHS in England

Sue Hill, Chief Scientific Officer, NHS England, UK

13:45     Genomic Test Evaluation Frameworks

Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research, The University of Queensland, Australia

14:00     Implementing Genomics in the Health Care System in Canada

Catalina Lopez-Correa, Chief Scientific Officer and Vice President, Sectors, Genome British Columbia, Vancouver, Canada

14:15     More than regulatory challenges for genomic medicine in Latin America

Alberto Lecaros, Observatory for BioEthics and Law, Universidad del Desarrollo, Santiago, Chile

14:30     Establishing a Latin American Translational Genomics Institute

Spiros Agathos, Dean, School of Life Sciences, Yachay Tech University, Ecuador

14:45     Implementation Science Meets Genomic Medicine: Ideas, Issues & Innovations

Jeffrey Braithwaite, Professor of Health Systems Research, Founding Director, Australian Institute of Health Innovation, Macquarie University, Australia

15:00     Fostering Genomic Literacy for Today and Tomorrow

Laura Lyman Rodriguez, Director, Division of Policy, Communications, and Education, National Human Genome Research Institute (NHGRI), USA

15:15     Genomic education for empowering the Multi-Disciplinary Healthcare

Dhavendra Kumar, Visiting Professor, Genomic Policy Unit, Faculty of Life Sciences & Education, University of South Wales, UK, Consultant in Clinical Genetics, University Hospital of Wales, UK

15:30 Panel discussion

 

16:00 BREAK

 

16:15 - 17:30 Breakout Sessions

A) National Programs: Implementation [Location: Platon]

Chair: Alan Shuldiner, Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA

B) Pharmacogenomics [Location: Platon]

Chair: George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical BiotechnologyUniversity of Patras, Greece

C) Policy [Location: Athina A]

Chair: Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research The University of Queensland, Australia

D) Education and Workforce [Location: Athina B]

Chair: Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham, USA

E) IT/Bioinformatics & Family Health History Project [Location: Poseidon A]

Chairs: Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Canada, Grant Wood, Senior Strategist, Intermountain Healthcare Clinical Genetics Institute, USA

F) Evidence [Location: Poseidon B]

Chairs: Marc Abramowicz, Professor and Head, Dept. of Medical Genetics, Université. Libre de Bruxelles, Brussels, Fahd Al-Mulla, Director of Genomic Medicine Center and Professor of Molecular Pathology,Kuwait University, Dasman Diabetes Institute, Kuwait

 

18:00 Depart for Dinner

Tour of Acropolis Museum

20:00 DINNER

Location: Acropolis Museum

 

Day 3 – Saturday April 29, 2017

07:00 - 08:00 G2MC Steering Committee Meeting (by invitation only)

08:00 Opening Remarks

Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA

Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research, The University of Queensland, Australia

 

SESSION VI: PHARMACOGENOMICS IN THE CLINIC: INTERNATIONAL PROGRESS

Moderator: George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras, Greece

 

08:10     Implementation of Pharmacogenomics in the Clinic

Sir Munir Pirmohamed, Professor, University of Liverpool, Wolfson Institute of Personalized Medicine, UK

08:20     Genomic Medicine; Safety first

Federico Innocenti, Associate Director; Associate Professor; Center of Pgarmacogenomics and Individualized Therapy; Associate Professor; University of North Carolina, Chapel Hill, USA

08:30     The Ubiquitous Pharmacogenomics (UPGx) project

Jesse Swen, Associate Professor, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Netherlands

08:40     PGx Activities in Latin America

Guilherme Suarez-Kurtz, Professor, Instituto Nacional de Câncer, Brazil

08:50     Public Health Pharmacogenomics

George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology,University of Patras, Greece

09:00     Implementation of PGx in the Austrian Healthcare System

Markus Paulmichl, Medical Advisor, Centre for Health and Bioresources, Austrian Institute of Technology, Austria

09:10     European Society of Pharmacogenomics

Ron van Schaik, Full Professor, Pharmacogenetics Erasmus Medical Center, Netherlands

09:20     Pharmacogenomics research and implementation in Africa

Collet Dandara, Professor, Department of Clinical & Laboratory Sciences, University of Cape Town, South Africa

09:30     The SEAPharm Consortium

Wasun Chantratita, Associate Professor, Department of Pathology, Ramathibidi Hospital, Thailand

09:40 Panel discussion

 

10:15 - 10:30 BREAK

 

10:30 - 12:00 Breakout Reports and Discussion

Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University

 

12:00 - 13:00 WORKING LUNCH [G2MC Steering Committee meeting (continued; by invitation only)]

 

SESSION VII: IMPLEMENTATION OF GENOMIC MEDICINE BY THE PRIVATE SECTOR

Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University

 

13:15     De novo assembly of Asian diploid genome (AK1)

Changhoon Kim, Director, Bioinformatics Institute, Macrogen, South Korea

13:30     The Science May be the Easy Part: Challenges and Solutions in Implementing a Molecular Diagnostic Test

James Wingrove, Vice President Technical Operations, Head of Research, CardioDx, USA

13:45     From human genetic insights to drug discovery impact

Nadeem Sarwar, President, Eisai AiM Institute, USA

14:00     Genomic Medicine Enabled Through Partnership

David Bentley, Vice President and Chief Scientist, Illumina, UK

 

14:15 Closing remarks

Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine,Biomedical Engineering and Pathology, Duke University, USA

Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia

 

14:30 MEETING ADJOURNS

 


 

Sponsors

 

Sponsors

 

We are grateful to the following corporate entities for generously supporting this event.

                        

               

 

Registration

 

Registration

Click here to register and submit an abstract.

Click here to register without submitting an abstract.

 

Accommodation

Click here to reserve your accommodation at the DIVANI Apollon Palace and Thalasso *.

* A special code to benefit from the discounted rate will be provided to the delegates of the 3rd G2MC Conference.

 

Connect With Us

Subscribe to all RSS or just the section
you care..

RSSFacebookTwitterFlickr

Looking for Golden Helix, Inc

Our Videos

Genetic Analysis in Translational medicine:

You are here: Home Education Golden Helix Conferences The Golden Helix Symposia Upcoming Symposium